BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 19120305)

  • 1. Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes.
    Kawasaki E; Kuriya G; Satoh T; Fujishima K; Moriuchi A; Fukushima K; Ozaki M; Abiru N; Yamasaki H; Eguchi K
    Ann N Y Acad Sci; 2008 Dec; 1150():248-51. PubMed ID: 19120305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
    Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
    J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.
    Ota T; Takamura T; Nagai Y; Bando Y; Usuda R
    Diabetes Res Clin Pract; 2005 Jan; 67(1):63-9. PubMed ID: 15620435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in prevalence of antibodies to GAD and IA-2 and their titers at diagnosis in children with slowly and rapidly progressive forms of type 1 diabetes.
    Urakami T; Yoshida A; Suzuki J; Saito H; Wada M; Takahashi S; Mugishima H
    Diabetes Res Clin Pract; 2009 Jan; 83(1):89-93. PubMed ID: 19019475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
    Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
    Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
    Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
    Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.
    Maugendre D; Sonnet E; Derrien C; Le Golff MC; Grais MC; Allannic H; Delamaire M
    Diabetes Metab; 1999 Mar; 25(1):28-33. PubMed ID: 10335421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children.
    Wahlberg J; Fredriksson J; Nikolic E; Vaarala O; Ludvigsson J;
    Pediatr Diabetes; 2005 Dec; 6(4):199-205. PubMed ID: 16390388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
    Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
    Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of protein tyrosine phosphatase-2beta antibody (IA-2betaA) in type 1 diabetes].
    Li H; Huang G; Zhang S; Wang X; Jin HL; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):939-42. PubMed ID: 18756962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.